Healthcare / BiotechnologyUpdated 2026-05-10 22:07 UTC

MIST stock hub

Milestone Pharmaceuticals Inc. has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

MISTis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

235.5M

NASDAQ

Market data

Live price

Current market quote for this ticker.

Current price

MIST

In the news

Latest news · MIST

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 12.3P50 18.4P75 33.1

Trailing P/En/a

P25 14.9P50 23.2P75 38.5

ROE-229.7

P25 -105.6P50 -46.5P75 -3.1

ROIC-46.2

P25 -63.1P50 -27.3P75 0.5

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All MIST market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

198

Groups with data

Currency

USD

Showing 198 of 198 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0001408443
Company name	Milestone Pharmaceuticals Inc.
Country	Canada
Country code	US
Cusip	59935V107
Employees	38
Employees Change	5%
Employees Change Percent	15.15
Enterprise value	$187.9M
Exchange	NASDAQ
Financial currency	USD
First seen	2026-05-09
Industry	Biotechnology
Isin	CA59935V1076
Last refreshed	2026-05-10
Market cap	$235.5M
Market cap category	Micro-Cap
Price	$1.92
Price currency	USD
Rev Per Employee	40,684.21x
Sector	Healthcare
Sic	2834
Symbol	MIST
Website	https://www.milestonepharma.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-26.78%
EV Sales Forward	4.1x
EV/Sales	121.54x
FCF yield	-20.95%
P/B ratio	5.64x
P/S ratio	152.32x
PS Forward	5.14x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Gross margin	100%
Gross Profit	$1.5M
Gross Profit Growth3 Y	-32.38%
Net Income	$-63.1M
Net Income Growth Years	0%
Pretax Margin	-4,078.78%
Profit Per Employee	$-1.7M
ROA	-41.08
Roa5y	-37.07
ROCE	-62.4
ROE	-229.7
Roe5y	-149.9
ROIC	-46.21

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	48.88%
Cagr3y	-18.82%
Cagr5y	-19.64%
EPS Growth Quarters	2
EPS Growth Years	0
Revenue Growth Years	0x
Revenue Growth3 Y	-32.38x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	$0.02
Assets	$113.6M
Cash	$106M
Current Assets	$111.9M
Current Liabilities	$14M
Debt	$58.4M
Debt Equity	$1.4
Equity	$41.8M
Interest Coverage	-16.19
Liabilities	$71.8M
Long Term Assets	$1.6M
Long Term Liabilities	$57.8M
Net Cash	$47.6M
Net Cash By Market Cap	$20.21
Net Cash Growth	219.39%
Net Debt Equity	$-1.14
Tangible Book Value	$41.8M
Tangible Book Value Per Share	$0.34
WACC	9.02

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	8.01
Net Working Capital	$-7.4M
Quick ratio	7.83
Working Capital	$97.9M
Working Capital Turnover	$0.02

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-34.84%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	48.84%
200-day SMA	1.89
3Y total return	-46.52%
50-day SMA	1.71
50-day SMA vs 200-day SMA	50under200
5Y total return	-66.49%
All Time High	27.95
All Time High Change	-93.13%
All Time High Date	2019-06-28
All Time Low	0.63
All Time Low Change	207%
All Time Low Date	2025-04-07
ATR	0.13
Beta	1.04
Beta1y	3
Beta2y	2.69
Ch YTD	-4.95
High	1.93
High52	3.06
High52 Date	2025-12-12
High52ch	-37.25%
Low	1.88
Low52	1
Low52 Date	2026-03-30
Low52ch	92%
Ma50ch	12.48%
Premarket Change Percent	2.12
Premarket Price	$1.93
Premarket Volume	4,775
Price vs 200-day SMA	1.43%
RSI	54.76
RSI Monthly	48.3
RSI Weekly	51.76
Sharpe ratio	0.88x
Sortino ratio	1.27
Total Return	-34.84%
Tr YTD	-4.95
Tr1m	19.26%
Tr1w	2.67%
Tr3m	9.09%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Analyst Count	3
Analyst Count Top	1
Analyst Price Target Top	$8
Analyst Ratings	Strong Buy
Analyst Ratings Top	Buy
Earnings EPS Estimate	$0.14
Earnings Revenue Estimate	45,131,000x
Operating Income	$-62.1M
Operating margin	-4,019.4
Price target	$8
Price Target Change	$317
Price Target Change Top	$317

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	105,111,024%
Float Percent	85.7%
Shares Insiders	0.92%
Shares Institutions	22.3%
Shares Out	122,649,269
Shares Qo Q	9.89%
Shares Yo Y	34.84%
Short Float	9.82%
Short Ratio	3.29
Short Shares	8.42

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$-56.8M
Average Volume	1,422,881.3x
Bv Per Share	0.34
CAPEX	$-302,000
Ch1m	19.26
Ch1w	2.67
Ch1y	48.84
Ch3m	9.09
Ch3y	-46.52
Ch5y	-66.49
Ch6m	12.28
Change	1.59%
Change From Open	1.05
Close	1.89
Days Gap	0.53
Depreciation Amortization	114,000
Dollar Volume	1,156,471.7
Earnings Date	2026-05-13
Earnings Time	bmo
EBIT	$-62.1M
EBITDA	$-62M
EPS	$-0.75
F Score	1
FCF	$-49.3M
FCF EV Yield	-26.26x
FCF Per Share	$-0.4
Financing CF	85,527,000
Fiscal Year End	December
Founded	2,003
Investing CF	11,246,000
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-03-20
Last Report Date	2025-12-31
Last Split Type	Never
Last10k Filing Date	2026-03-20
Ma150	1.94
Ma150ch	-1.03%
Ma20	1.95
Ma20ch	-1.29%
Net CF	47,732,000
Next Earnings Date	2026-05-13
Open	1.9
Optionable	Yes
Position In Range	81.82
Post Close	1.92
Postmarket Change Percent	0.82
Postmarket Price	$1.94
Ppne	1,640,000
Pre Close	1.89
Price Date	2026-05-08
Ptbv Ratio	5.64
Relative Volume	0.42x
Revenue	1,546,000x
SBC By Revenue	482.6x
Share Based Comp	7,461,000
Tr6m	12.28%
Volume	602,329
Z Score	-4.81

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does MIST pay a dividend?

Capital-return profile for this ticker.

Performance

MIST stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns MIST?

Insider, institutional, and short-interest positioning.

Institutional ownership

+22.3%

Float: +85.7% of shares outstanding

Insider ownership

+0.9%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

MIST momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

54.8

Neutral momentum band

Price vs 200-day MA

+1.4%

50/200-day relationship not available

Beta (5Y)

1.04

Moves roughly with the market

Sharpe ratio

0.88

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About MIST

Hub-level FAQ points readers to the deeper analysis pages.

What is the current MIST stock rating?

Milestone Pharmaceuticals Inc. is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full MIST analysis?

The full report lives at /stocks/MIST/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for MIST?

The latest report frames MIST around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the MIST page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.